Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus

Clinical and Experimental Immunology

Volumn 160, Issue 3, 2010, Pages 348-358

  Kim, J R ^a   Mathew, S O ^a   Patel, R K ^b   Pertusi, R M ^c   Mathew, P A ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b University of North Texas Health Science Center   (United States)

^c HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

2B4; CS1; PBMC; SLAM family receptors; SLE

Indexed keywords

AZATHIOPRINE; CD150 ANTIGEN; CD244 ANTIGEN; CD319 ANTIGEN; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIGENS, CD; AUTOCRINE COMMUNICATION; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 1; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 77952212719     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04116.x     Document Type: Article

References (60)

1. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001 15 : 397 408. (Pubitemid 32907387)
2. Kono DH, Burlingame RW, Owens DG et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994 91 : 10168 10172.
3. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994 1 : 219 229. (Pubitemid 2102417)
4. Drake CG, Rozzo SJ, Hirschfeld HF, Smarnworawong NP, Palmer E, Kotzin BL. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol 1995 154 : 2441 2447.
5. Morel L, Yu Y, Blenman KR, Caldwell RA, Wakeland EK. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996 7 : 335 339. (Pubitemid 126426665)
6. Wandstrat AE, Nguyen C, Limaye N et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004 21 : 769 780. (Pubitemid 39626668)
7. Moser KL, Neas BR, Salmon JE et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998 95 : 14869 14874.
8. Tsao BP, Cantor RM, Kalunian KC et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997 99 : 725 731.
9. Tsao BP, Cantor RM, Grossman JM et al. Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2002 46 : 2928 2936.
10. Sayos J, Wu C, Morra M et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998 395 : 462 469. (Pubitemid 28462434)
11. Nichols KE, Harkin DP, Levitz S et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998 95 : 13765 13770. (Pubitemid 28523047)
12. Coffey AJ, Brooksbank RA, Brandau O et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998 20 : 129 135. (Pubitemid 28455444)
13. Veillette A, Zhang S, Shi X, Dong Z, Davidson D, Zhong MC. SAP expression in T cells, not in B cells, is required for humoral immunity. Proc Natl Acad Sci USA 2008 105 : 1273 1278. (Pubitemid 351397043)
14. Howie D, Laroux FS, Morra M et al. Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions. J Immunol 2005 174 : 5931 5935. (Pubitemid 40663778)
15. Wang N, Satoskar A, Faubion W et al. The cell surface receptor SLAM controls T cell and macrophage functions. J Exp Med 2004 199 : 1255 1264. (Pubitemid 38620262)
16. Graham DB, Bell MP, McCausland MM, et al. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. J Immunol 2006 176 : 291 300.
17. Latchman Y, McKay PF, Reiser H. Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol 1998 161 : 5809 5812. (Pubitemid 28535943)
18. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998 188 : 2083 2090. (Pubitemid 28562525)
19. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993 151 : 60 70. (Pubitemid 23206971)
20. Mathew PA, Garni-Wagner BA, Land K et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 1993 151 : 5328 5337. (Pubitemid 23332342)
21. Stepp SE, Schatzle JD, Bennett M, Kumar V, Mathew PA. Gene structure of the murine NK cell receptor 2B4: presence of two alternatively spliced isoforms with distinct cytoplasmic domains. Eur J Immunol 1999 29 : 2392 2399. (Pubitemid 29378107)
22. Schatzle JD, Sheu S, Stepp SE, Mathew PA, Bennett M, Kumar V. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc Natl Acad Sci USA 1999 96 : 3870 3875. (Pubitemid 29169003)
23. Mathew SO, Rao KK, Kim JR, Bambard ND, Mathew PA. Functional role of human NK cell receptor 2B4 (CD244) isoforms. Eur J Immunol 2009 39 : 1632 1641.
24. Kumaresan PR, Mathew PA. Structure of the human natural killer cell receptor 2B4 gene and identification of a novel alternative transcript. Immunogenetics 2000 51 : 987 992.
25. Nakajima H, Cella M, Bouchon A et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur J Immunol 2000 30 : 3309 3318.
26. Parolini S, Bottino C, Falco M et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000 192 : 337 346. (Pubitemid 30629159)
27. Tangye SG, Phillips JH, Lanier LL, Nichols KE. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J Immunol 2000 165 : 2932 2936.
28. Garland RJ, El-Shanti N, West SE et al. Human CD8+ CTL recognition and in vitro lysis of herpes simplex virus-infected cells by a non-MHC restricted mechanism. Scand J Immunol 2002 55 : 61 9. (Pubitemid 34227259)
29. Smith GM, Biggs J, Norris B, Anderson-Stewart P, Ward R. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J Clin Immunol 1997 17 : 502 509. (Pubitemid 28008109)
30. Sivori S, Falco M, Marcenaro E et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc Natl Acad Sci USA 2002 99 : 4526 4531. (Pubitemid 34286018)
31. Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG. Cutting edge: regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. J Immunol 2001 167 : 6706 6710. (Pubitemid 33144158)
32. Lee KM, Bhawan S, Majima T et al. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J Immunol 2003 170 : 4881 4885. (Pubitemid 36554715)
33. Lee KM, McNerney ME, Stepp SE et al. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 2004 199 : 1245 1254.
34. Vaidya SV, Stepp SE, McNerney ME et al. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J Immunol 2005 174 : 800 807.
35. Suzuki A, Yamada R, Kochi Y et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat Genet 2008 40 : 1224 1229.
36. Kumaresan PR, Lai WC, Chuang SS, Bennett M, Mathew PA. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol Immunol 2002 39 : 1 8. (Pubitemid 35245377)
37. Lee JK, Mathew SO, Vaidya SV, Kumaresan PR, Mathew PA. CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes. J Immunol 2007 179 : 4672 4678.
38. Lee JK, Boles KS, Mathew PA. Molecular and functional characterization of a CS1 (CRACC) splice variant expressed in human NK cells that does not contain immunoreceptor tyrosine-based switch motifs. Eur J Immunol 2004 34 : 2791 2799.
39. Cruz-Munoz ME, Dong Z, Shi X, Zhang S, Veillette A. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat Immunol 2009 10 : 297 305.
40. Hsi ED, Steinle R, Balasa B et al. CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma. Clin Cancer Res 2008 14 : 2775 2784.
41. Tai YT, Dillon M, Song W et al. Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu. Blood 2008 112 : 1329 1337.
42. Tai YT, Soydan E, Song W et al. CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells. Blood 2009 113 : 4309 4318.
43. Graham DS, Vyse TJ, Fortin PR et al. Association of LY9 in UK and Canadian SLE families. Genes Immun 2008 9 : 93 102.
44. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 25 : 1271 1277. (Pubitemid 13221242)
45. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 40 : 1725.
46. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 35 : 630 640.
47. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005 121 : 1109 1121. (Pubitemid 40884400)
48. Schwartzberg PL, Mueller KL, Qi H, Cannons JL. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat Rev Immunol 2009 9 : 39 46.
49. Calpe S, Wang N, Romero X et al. The SLAM and SAP gene families control innate and adaptive immune responses. Adv Immunol 2008 97 : 177 250. (Pubitemid 351697820)
50. Veillette A, Dong Z, Latour S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 2007 27 : 698 710. (Pubitemid 350102266)
51. Dorner T, Jacobi AM, Lipsky PE. B cells in autoimmunity. Arthritis Res Ther 2009 11 : 247.
52. Culton DA, Nicholas MW, Bunch DO et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 2007 27 : 53 68.
53. Nicholas MW, Dooley MA, Hogan SL et al. A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol 2008 126 : 189 201.
54. Jacobi AM, Odendahl M, Reiter K et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2003 48 : 1332 1342. (Pubitemid 36554532)
55. Odendahl M, Jacobi A, Hansen A et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000 165 : 5970 5979.
56. Bradshaw S, Zheng WJ, Tsoi LC, Gilkeson G, Zhang XK. A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin Immunol 2008 129 : 19 30.
57. Mathew SO, Vaidya SV, Kim JR, Mathew PA. Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element. Biochem Biophys Res Commun 2007 355 : 483 487.
58. Sandusky MM, Messmer B, Watzl C. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Eur J Immunol 2006 36 : 3268 3276. (Pubitemid 44932728)
59. Zhong MC, Veillette A. Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity. J Biol Chem 2008 283 : 19255 19264.
60. Kumar KR, Li L, Yan M et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006 312 : 1665 1669. (Pubitemid 43902668)